Issue 51
Cardiopulmonary
resuscitation in adults
The United Kingdom’s guidelines on advanced life support
for adults were updated in 1997 and endorsed by the European Resuscitation
Council in 1998. During 1999 and 2000 the American Heart Association hosted
three meetings of international organisations in Dallas to evaluate the evidence
on resuscitation. The sets of guidelines that resulted from the international
consensus document have a stronger evidence base than their predecessors but
have retained their simplicity.
Experts at the Dallas meetings included representatives from
the American Heart Association, the European Resuscitation Council, the Heart
and Stroke Foundation of Canada, the Australian Resuscitation Council, the New
Zealand Resuscitation Council, the Resuscitation Council of Southern Africa, the
Latin American Resuscitation Council, and Japan. All aspects of resuscitation
were reviewed, and the quality of the evidence supporting each resuscitation
intervention was appraised.
The European Resuscitation Council has accepted most of the
recommendations from the international consensus document, and its revised
guidelines for adults have been summarised in three papers. The Resuscitation
Council (UK) has adopted the updated European guidelines in their entirety, and
these are incorporated into its latest manual for providers of courses on
advanced life support.
Lay people will no longer be trained to check for the carotid
pulse to confirm cardiac arrest. Several studies have shown that assessment of
the carotid pulse by lay people is time consuming and unreliable: their
assessment is wrong in up to 50% of cases. This change in the guidelines is an
example of evidence based practice applied to resuscitation. Healthcare
professionals will continue to be taught to check the carotid pulse to confirm
cardiac arrest. The ratio of chest compressions to ventilations is now 15:2 for
both one person and two-person cardiopulmonary resuscitation. A ratio of 15:2
provides more chest compressions per minute than a ratio of 5:1. The external
cardiac compression rate remains 100 a minute.
Once the trachea has been intubated, chest compressions, at a
rate of 100 a minute, should continue uninterrupted (except for defibrillation
or pulse checks when indicated), and ventilation should be continued at roughly
12 breaths a minute. A pause in the chest compressions allows the coronary
perfusion pressure to fall substantially. When compressions are resumed there is
some delay before the original coronary perfusion pressure is restored. Thus,
chest compressions without interruption for ventilation result in a
substantially higher mean coronary perfusion pressure.
As an extension of this concept, using only compression in
cardiopulmonary resuscitation is now advocated as an option in telephone
assisted cardiopulmonary resuscitation. This follows evidence that many lay
rescuers are reluctant to perform mouth to mouth ventilation and consequently
fail to provide any basic life support. These ideas are still at the research
stage, but progress is being made rapidly
The new guidelines include the option to use biphasic shocks.
In defibrillation, success rates of repeated biphasic shocks at £
200J are the same as or higher than success rates of monophasic waveforms of
escalating energy (200 J, 200 J, 360 J).
A number of changes have been made to the recommendations for
drug treatment in advanced life support. An intravenous bolus of amiodarone 300
mg should be considered when the patient has ventricular fibrillation or when
pulseless ventricular tachycardia does not respond to three shocks (2300 J, 200
J, 360 J). Atropine 3 mg is now indicated for pulseless electrical activity
(electromechanical dissociation) with a ventricular rate of less than 60 a
minute, as well as for asystole. The international guidelines recommend a single
intravenous dose of 40 units of vasopressin as an alternative to adrenaline in
cases of ventricular fibrillation or pulseless ventricular tachycardia
refractory to three initial shocks. The European Resuscitation Council and the
Resuscitation Council (UK) are awaiting further evidence before adopting this
recommendation and will continue to recommend epinephrine (adrenaline) 1 mg
every three minutes during cardiopulmonary resuscitation. A recent study of
cardiac arrests occurring in hospital failed to detect any advantage for
survival of vasopressin over epinephrine. The administration of "high dose”
epinephrine (5 mg) and bretylium is no longer recommended.
The advanced life support algorithm, which is relatively
simple and universal, remains essentially unchanged. The peri-arrest algorithms
of the European Resuscitation Council have been modified, and an algorithm
dealing specifically with atrial fibrillation has been added. Difficulty in
obtaining the raw material for isoprenaline has driven the recommendation of low
dose epinephrine as an alternative treatment for symptomatic bradycardias
resistant to atropine. Amiodarone is the preferred drug for treating broad
complex tachycardias, although lidocaine (lignocaine) remains an alternative.
The narrow complex tachycardia algorithm now includes the recommendation of a
synchronised direct current shock if the heart rate exceeds 250 beats a minute
and the patient has no pulse. The algorithm for the management of atrial
fibrillation is complex. Patients are classed as having high, intermediate, or
low risk, and the treatment options depend partly on the duration of the atrial
fibrillation. The new guidelines are clearly more evidence based. The challenge
is to prove their effectiveness in terms of improved outcome for patients in
cardiac arrest.
Ref:
European resuscitation council guidelines
Back to top
Evidence-based
education website
On behalf of a team of North Carolina university and Area
Health
Education Center librarians, we are pleased to announce the completion
of a new Evidence-Based education web site:
This site provides a collection of resources that support
teaching and learning EBM for faculty, librarians, students, and other health
care professionals.
Ref:
(web)
Back to top
Impact of Effective
Health Care bulletin on treatment of persistent glue ear in children: time
series analysis
During the 1980s, surgery for chronic otitis media with
effusion (glue ear) increased greatly without obvious reason. An Effective
Health Care bulletin on the treatment of persistent glue ear in children was
distributed nationally to NHS decision-makers in 1992. Based on systematic
review, the bulletin concluded that surgery should be restricted to children
with an extended period of substantial hearing impairment, with persistence and
severity established by watchful waiting. Surgery rates before and after
distribution of the bulletin were evaluated.
Quarterly numbers of D151 procedures – insertion of a
ventilation tube through the tympanic membrane – performed in children aged
under 15 in England from 1989 to 1996 were obtained from the hospital episodes
system. Per capita regional and national rates for this procedure were
calculated.
A generalised linear model with a heterogeneous first order
autoregressive structure and repeated measures by region was applied. This
approach consistently identifies the best autoregressive structure (the model
adjusts for the relatedness of sequential observations over time). We
investigated regional variations in surgical rates by comparing standard error
terms from the model before and after distribution of the bulletin.
Overall, the model included data from 14 regions, each of
which provided results from 28 quarters, half before and half after distribution
of the bulletin.
In 1992 grommet insertions were conducted at a rate of 2.1
per 1000 children, with regional rates varying by a factor of two. A small
increase in the rate during the three years before distribution of the bulletin
became a decrease in the four years after publication (-0.044 (-0.080 to –0.011);
P<0.0001). The decrease in quarterly rate from 1992 onwards was seen
consistently across the regions.
The changing trend in surgery suggests that 89,800 procedures
were avoided nationally in the four years after the bulletin, providing a
theoretical saving of £27m at 1992-3 prices. Regional variations in the numbers
of surgical procedures undertaken were 30% smaller after distribution of the
bulletin than before (SE 0.0169 v 0.0242). Our findings were not substantially
altered by analysing procedures under the broader code D15 (drainage of the
middle ear) or by age range.
Distributing printed recommendations to decision makers may
influence surgery rates, since a trend towards a reduction in the number of
grommet operations was seen after distribution of the bulletin. Rates for
tonsillectomy – another elective procedure in the same specialty – increased
steadily over the same period, suggesting that the change was specific to
persistent glue ear and thus was related to the bulletin.
The change cannot be attributed to the bulletin alone, which
was commissioned because of pre-existing concerns about appropriate use of the
procedure. Its publication received coverage in the medical and academic press,
possibly encouraging doctors to examine their own practices and bring about
behavioural change.
Surgery rates were reduced, and there was an apparent improvement in the
equality of care, but our results do not provide information on quality of care
delivered by either general practitioners or surgeons. Adherence to watchful
waiting principles may have promoted more appropriate (and reduced) patient
selection; alternatively, primary care physicians alerted by media concerns may
have reduced referral rates. Establishing the link between health service
activity and quality of care remains difficult.
The estimated savings from reduced surgery (£27m) are considerably greater
than the approximate production cost of the bulletin (£25,000). Another
bulletin addressing the prescribing of selective serotonin reuptake inhibitors
demonstrated a similar profile of costs. Although the apparent healthcare
savings are impressive, the impact on health outcomes, costs of alternative care
received by patients, and costs of other health promoting activities remain
unknown.
Ref: This is a
reference to the Bandolier version
Back to top
|
 |